HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Herpes zoster and postherpetic neuralgia in older adults.

Abstract
Herpes zoster (HZ) afflicts millions of older adults annually and causes significant suffering from acute and chronic pain, or postherpetic neuralgia (PHN). HZ is caused by the reactivation of varicella-zoster virus (VZV) in sensory ganglia in the setting of age, disease, and drug-related decline in cellular immunity. VZV-induced neuronal destruction and inflammation cause the pain, interference with activities of daily living, and reduced quality of life. The optimal treatment of HZ requires early antiviral therapy and pain management. For PHN, evidence-based pharmacotherapy can reduce pain burden. The zoster vaccine is effective in reducing pain burden and preventing HZ and PHN in older adults.
AuthorsKenneth Schmader
JournalClinics in geriatric medicine (Clin Geriatr Med) Vol. 23 Issue 3 Pg. 615-32, vii-viii (Aug 2007) ISSN: 0749-0690 [Print] United States
PMID17631237 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review)
Chemical References
  • Antiviral Agents
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antiviral Agents (therapeutic use)
  • Global Health
  • Herpes Zoster (complications, drug therapy, epidemiology)
  • Humans
  • Morbidity (trends)
  • Neuralgia, Postherpetic (drug therapy, epidemiology, etiology)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: